Dr. James Ferguson

Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award. Dr. Silverman is rated as an Elite provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, Pulmonary Fibrosis, and Vulvectomy.

Dr. George R. Washko, Jr. is a physician at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Georgetown University School of Medicine. He then completed a residency in internal medicine at Beth Israel Deaconess Medical Center, followed by a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary disease.Dr. Washko is a National Institutes of Health-funded investigator in chronic obstructive pulmonary disease (COPD), specifically focusing his work in imaging and quantitative image analysis. As the regional principal investigator on the National Heart, Lung, and Blood Institute’s COPD clinical research network, he is researching therapies for the prevention and treatment of COPD. He has written over 140 peer-reviewed publications, is the recipient of the Parker B. Francis fellowship and is a member of the American Society of Clinical Investigation. Dr. Washko is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Acute Interstitial Pneumonia, and Interstitial Lung Disease.

Samuel Ash is an Intensive Care Medicine provider in South Weymouth, Massachusetts. Dr. Ash has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Interstitial Lung Disease.